BindingDB logo
myBDB logout

10 articles for thisTarget

The following articles (labelled with PubMed ID or TBD) are for your review
PMIDDataArticle TitleOrganization
18337097 64 Lead identification of 2-iminobenzimidazole antagonists of the chemokine receptor CXCR3.EBI Abbott Bioresearch Center
22130135 55 Discovery of potent and specific CXCR3 antagonists.EBI Amgen Inc.
21764306 149 Special ergolines efficiently inhibit the chemokine receptor CXCR3 in blood.EBI Novartis Institutes for BioMedical Research
21277198 71 II. SAR studies of pyridyl-piperazinyl-piperidine derivatives as CXCR3 chemokine antagonists.EBI Ligand Pharmaceuticals
19632842 65 Optimization of a series of quinazolinone-derived antagonists of CXCR3.EBI Amgen Inc.
19631529 74 Imidazo-pyrazine derivatives as potent CXCR3 antagonists.EBI Amgen Inc.
19783143 65 Special ergolines are highly selective, potent antagonists of the chemokine receptor CXCR3: discovery, characterization and preliminary SAR of a promising lead.EBI Novartis Institutes for BioMedical Research
19014886 83 Camphor sulfonamide derivatives as novel, potent and selective CXCR3 antagonists.EBI GlaxoSmithKline
18032038 38 Development of CXCR3 antagonists. Part 3: Tropenyl and homotropenyl-piperidine urea derivatives.EBI UCB Inflammation Discovery
17097877 40 Identification and structure-activity relationships of 1-aryl-3-piperidin-4-yl-urea derivatives as CXCR3 receptor antagonists.EBI UCB